Studies for Congenital Disorders of Glycosylation

Studies

How do I learn more about current open studies?

You may contact the study team members at a site for the most up to date information regarding available studies and study details. Study team members may be found on the Clinical Sites page. Studies regarding CDG may also be searched for on ClinicalTrials.gov. A list of our studies can be found below.

How do I participate in a study?

Please reach out to a clinical site for study details and to find out if you qualify.

Current studies

Clinical and Basic Investigations into Congenital Disorders of Glycosylation (NCT#04199000) · currently enrolling patients
A Randomized, Double-blind, Placebo-controlled Study Evaluating Acetazolamide Efficacy in Ataxia in PMM2-CDG (NCT#04679389) · currently enrolling patients
Large-Scale Metabolomic Profiling for the Diagnosis of Inborn Errors of Metabolism (NCT#04201067) · not recruiting

The Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). FCDGC is funded under grant number U54NS115198 as a collaboration between NCATS, the National Institute of Neurological Disorders and Stroke (NINDS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the Office of Dietary Supplements (ODS). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and NINDS under grant number TR002818.

Frontiers in Congenital Disorders of Glycosylation (FCDGC)

Studies

How do I learn more about current open studies?

How do I participate in a study?

Current studies